Cong to face 2018 Karnataka polls under collective leadership: KPCC chief

Bengaluru, Jan 30: The BJP government of Karnataka has given green signal to the proposal of hiking milk prices by Rs 2 per litre.

The new prices will come into effect from February 1. Seeking revision of prices, the Karnataka Milk Federation (KMF) had submitted a proposal last week to the state government. Alongside the revision of milk prices, the state government has also hiked the prices of curd by Rs 2 per liter.

The sudden hike in the prices of milk, curd is likely to have a cascading effect on the milk related beverages such as coffee, tea, and milkshakes with hoteliers and eateries mulling to increase the prices of coffee and tea following the hike in prices.

Sources in the state government revealed to DH that out of Rs 2, farmers will be getting a lion’s share as their accounts will be credited with Rs 1. Another 40 paise will be given to the farmers towards the insurances of their livestock.

Another 40 paise will go to the milk salesmen in the form of commission. The remaining 20 paise will be distributed among the workforce at the milk cooperative unions as an additional incentive.

Mysuru, Jan 20: Fears over CAA and proposed NRC have affected the ongoing 7th economic census. Following complaints of violence against enumerators and registration of FIR with people declining to give information, the state government has asked deputy commissioners and superintendents of police to hold awareness programmes about it.

The planning, programme monitoring & statistics department has requested the home department to provide cooperation at the police station level while additional chief secretary P Ravi Kumar, in his letter to all DCs, has asked them to create awareness. According to sources, enumerators in T Narasipura town of Mysuru district faced resistance as some residents misunderstood the reason for this census.

A senior officer of the directorate of economics and statistics said that additional chief secretary (ACS- Planning, Programme Monitoring & Statistics Department) Shalini Rajneesh has written to the home department and superintendents of police of all districts seeking their help to create awareness about the economic census.

According to sources in the directorate, in many places, people are refusing to share information under the misconception that it is related to CAA/ NRC. “Many are mistaken about the economic census. As a precaution, police help has been sought,” an officer said.

Authorities in Mysuru said the 7th economic census began on December 20 and will conclude on March 30.

“In Mysuru city alone, we need to cover a population of 11 lakh. In T Narasipura, we faced problems due to misconceptions about Census and CAA. We reported the incident which happened in an area where minorities reside in large numbers,” he explained. Mysuru SP CB Rishyanth said his office has not received any direction in this matter.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.